In order to increase the confidence in the conclusion that cypermethrin does not have endocrine disrupting properties, the applicants should provide an updated assessment, in accordance with point 2.2(b) of Annex II to Regulation (EC) No 1107/2009, of the criteria laid down in points 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009, as amended by Regulation (EU) 2018/605 and in accordance with the guidance for the identification of endocrine disruptors [Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009. https://www.efsa.europa.eu/en/efsajournal/pub/5311.].
Recital 16, Regulation (EU) 2021/2049
In forcesince 24 Nov 2021cited 1×
Judgment of the General Court (Fourth Chamber) of 21 February 2024 (Extracts). Pesticide Action Network Europe (PAN Europe) v European CommiDecision
21 Feb 2024 · 62022TJ0536